Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Clinical Trial ID: NCT03770858

Description

Pilot study of flexible and wearable sensor to monitor nocturnal scratching behavior

Present an advanced flexible, and wearable sensor intimately coupled to the skin that can measure the full spectrum of relevant physiological parameters associated with atopic dermatitis including scratch count, scratch duration, scratch intensity, heart rate, heart rate variability and respiratory rate.


Criteria

Inclusion Criteria: - Participants with mild to moderate atopic dermatitis ages 2 years or older. This will be determined by clinical diagnosis of AD according to the Hanifin and Rajka criteria with a baseline Investigators Global Assessment score of mild (2) or moderate (3) - Systemic therapy use (e.g. oral corticosteroid, cyclosporine, methotrexate, phototherapy) within 28 days of subject enrollment - Topical corticosteroid use or topical calcineurin inhibitor use within 14 days of subject enrollment - Willingness and ability to set up an infrared video camera nightly - Willing to apply topical crisaborole twice daily to affected atopic dermatitis areas of the body Exclusion Criteria: - Active skin or systemic infection - Inability to operate a smartphone or video camera - Active atopic dermatitis on he dorsum of the hand or suprasternal notch

  • Start Date

    2019-04-01

  • Last Updated

    2019-10-25

  • Sponsor

    Pfizer

  • Condition Name

    Atopic Dermatitis

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.